ThinkstockWhile the battle rages on Wall Street on which way the price of oil ultimately goes, investors in the refiners are watching close for a blowout in the difference between Brent crude and Louisiana…
Is Liberty Media's decision to reduce its stake in Barnes & Noble a matter of stepping aside so the bookseller can spread its wings, or is it throwing in the towel on the company…
Wikimedia CommonsLike most of the firms we follow on Wall Street, RBC has updated its top stocks picks for April. With first-quarter earnings right around the corner, and the stock market trading once again…
New drug innovations are affecting the way that physicians treat such debilitating and deadly diseases as cancer. In a new research report, Jefferies presents the top drug innovations that investors should follow for 2014.
ThinkstockA recent survey of chief information officers by UBS shows that expected information technology (IT) budget growth this year should be right-in-line with prior surveys. Most importantly, more than 60% of the CIOs are…
Intel may still be the world's largest chipmaker, but in many ways it is still playing catch-up with consumers' shift away from PCs to mobile devices. So it will establish a $100 million fund…
ThinkstockInvestors who own consumer discretionary stocks have been battered this year. The sector is down 4.53% and is the worst overall performer in the S&P. After being a market leader the past two years,…
courtesy of Cisco SystemsThe market exploded to end the first quarter, and once again investors are shaking their heads. After three months with much more volatility than all of 2013, we end up just…
Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to revive a patent on its top-selling multiple-sclerosis drug.
Monday the state of New York joined a federal lawsuit against FedEx alleging that it illegally delivered 140 tons of contraband cigarettes in defiance of a 2006 agreement to cease the practice.
In a new research report, UBS analysts highlight five top technology stocks that, despite their solid credentials, may be ready to roll over. These stocks are overbought, but not over-the-hill.
Going against the grain can be good, especially in a market that feels a little toppy. In a new research report, Credit Suisse analysts highlight contrarian stocks to buy that go against the grain.
Wikimedia CommonsOne good thing about momentum corrections and sell-offs is they often give investors anxious to own some of the top names a far better entry point. While the market gyrations lately have not…
courtesy of Pandora MediaMomentum stocks are the greatest things in the world when the market goes up like it did last year. There is always somebody willing to buy the stocks high under the…
Sears on Thursday introduced Now + Here, a new fast-fashion shop within its stores and on its website. Because the first thing you think of when you hear the name Sears is … fashion?
In a new report, the team at Oppenheimer highlights the stocks that are the market leaders in network security. Investors looking for solid growth in technology for their portfolios should consider these top stocks.
GE Aviation has announced plans to break ground on a $100-million jet-engine plant in Lafayette, Ind., later this year. The plant will assemble the LEAP engine Airbus and Boeing passenger jets.
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to the carnage. While…
Frank Golhen, via Wikimedia CommonsWith volatility edging ever higher, investors have to look for at least a synthetic hedge to help them should there be a sizable correction. One of the best is solid…
After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early March, especially in Celgene, Medivation and Pharmacyclics.